Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

IBC Program Contact and Referral Information

  • To make an appointment, call 877-442-3324.

    After scheduling, one of our nurses will call you to answer your questions and help you prepare for the appointment.

    For more information about the Inflammatory Breast Cancer Program, call 617-632-2311.

    IBC Information for Referring Physicians

    The IBC Program offers highly specialized evaluation and care for patients with this rare and aggressive form of breast cancer that is frequently difficult to detect and often presents at an advanced stage.

    To refer a patient for diagnosis and treatment for inflammatory breast cancer, call 877-332-4294.

    Indications for Referral

    Unlike other forms of breast cancer, which can be identified by a mass, inflammatory breast cancer is more challenging to diagnose. It presents within the breast more diffusely, often without a well-defined mass. IBC presents with more lymphatic involvement within the breast which causes the breast to feel thick or heavy and makes diagnosis more difficult. Routine imaging, such as mammogram, is often unreliable.

    Patients who present with redness, swelling, pain, or itchiness of the breast or thickening of the skin on the breast, with ridging or dimpling, should be referred to a specialist for evaluation and a clinical examination and biopsy to confirm diagnosis.

    While IBC shares clinical similarities to mastitis, if a patient does not respond to antibiotic treatment for mastitis, a specialist should be consulted about inflammatory breast cancer. Specialists involved with our Inflammatory Breast Cancer Program are available to provide guidance and assistance with diagnosis.

  • New Patient Appointments

    Make Appointment Online
    Dana-Farber Brigham Cancer Center logo
    US News adult badge - smaller
  • Inflammatory Breast Cancer Program Patient Forum

    The Inflammatory Breast Cancer Program hosted its 6th Annual Patient Forum in April 2023. Presentations included patient-care-focused scientific information in the field of inflammatory breast cancer for patients, families, and loved ones. Check back for information about the 2024 forum.

    View forum recordings